Skip to main content
Politics

Key FDA committee unanimously recommends its first vaccine since 2023

Key FDA committee unanimously recommends its first vaccine since 2023

Feed excerpt — reported by NPR Politics

All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at NPR Politics →

Original Source

This article was syndicated from NPR Politics. All rights remain with the original publisher.